References
- Glick H, Briggs AH, Po1sky D. Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses. Expert Rev. Phatmacoeconomics Outcomes Res. 1,25-36 (2002).
- Sendi P, Gafni A, Birch S. Opportunity costs and uncertainty in the economic evaluation of healthcare interventions. Health Econ. 11, 23–31 (2002).
- Sendi PP, Craig B, Pfluger D et al. Systematic validation of disease models for pharmacoeconomic evaluations. j Eval Gun. Pract. 5,283–295 (1999).
- Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl. j Merl 296, 716–721 (1977).
- Birch S, Gafni A. Cost-effectiveness/utility analysis. Do current decision rules lead us to where we want to be? j Health Econ. 11, 279–296 (1992).
- Laupacis A, Feeny D, Detsky AS et al How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can. Med. Assoc. 146,473–482 (1992).
- Gafni A, Birch S. Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem. Can. Med. Assoc. J. 148,913–917 (1993).
- Stinnett AA, Paltiel AD. Mathematical programming for the efficient allocation of healthcare resources. J. Health Econ. 15, 641–653 (1996).